Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (81-90 of 285) with videos related to

Pageof 29
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 16, 2016
Reply: Dyspnea in Heart Failure: A Multiheaded BeastKirk Kee, Christopher Stuart-Andrews, Matthew J Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2025
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 17, 2011
Automated detection of the phase III slope during inert gas washout testingChristopher R Stuart-Andrews, Vanessa J Kelly, Scott A Sands, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Peripheral lung function in patients with stable and unstable asthmaBruce R Thompson, Jo A Douglass, Matthew J Ellis, et al.
Pediatric Pulmonology|September 9, 2021
Development of the A-STEP: A new incremental maximal exercise capacity step test in cystic fibrosisLisa M Wilson, Matthew J Ellis, Rebecca L Lane, et al.
Breast Cancer Research : BCR|March 3, 2011
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancerCesar G Sanchez, Cynthia X Ma, Robert J Crowder, et al.
European Journal of Applied Physiology|May 25, 2021
Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controlsAndrew T Jeklin, Fergus Sully, Darragh Flannery, et al.
Pageof 29

Showing results (81-90 of 285) with videos related to

Sort By:
Pageof 29
American Journal of Respiratory and Critical Care Medicine|September 16, 2016
Reply: Dyspnea in Heart Failure: A Multiheaded BeastKirk Kee, Christopher Stuart-Andrews, Matthew J Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2025
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 17, 2011
Automated detection of the phase III slope during inert gas washout testingChristopher R Stuart-Andrews, Vanessa J Kelly, Scott A Sands, et al.
Breast Cancer Research and Treatment|September 16, 2019
Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohortAngela S Cheng, Samuel C Y Leung, Dongxia Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON TrialJohn F R Robertson, Zhimin Shao, Shinzaburo Noguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Peripheral lung function in patients with stable and unstable asthmaBruce R Thompson, Jo A Douglass, Matthew J Ellis, et al.
Pediatric Pulmonology|September 9, 2021
Development of the A-STEP: A new incremental maximal exercise capacity step test in cystic fibrosisLisa M Wilson, Matthew J Ellis, Rebecca L Lane, et al.
Breast Cancer Research : BCR|March 3, 2011
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancerCesar G Sanchez, Cynthia X Ma, Robert J Crowder, et al.
European Journal of Applied Physiology|May 25, 2021
Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controlsAndrew T Jeklin, Fergus Sully, Darragh Flannery, et al.
Pageof 29